R&D News | pharmaphorum

News

Biotts claims a first with insulin delivery across skin

Polish drug delivery company Biotts says it has demonstrated delivery of insulin across the skin for the first time without the use of an injection system.

News

Prime editing comes of age as FDA clears human trials

Prime Medicine has been given the go-ahead by the FDA for the first human trial of its prime editing technology, which promises to deliver one-shot therapies for a range o

News

Ono swoops on Deciphera in $2.4 billion takeover

Japan’s Ono Pharma has bolstered its cancer pipeline with a $2.4 billion agreement to buy Deciphera Pharma of the US and its fast-growing gastrointestinal stromal tumour (

News

Ex-Ironwood CEO Mark Mallon pops up at George Medicines

UK start-up George Medicines has named Mark Mallon as its new chief executive, who will oversee the company as it tries to get its triple therapy for high blood pressure o

News

Is pharma’s interest in orphan drugs waning?

For many years, orphan drugs for rare diseases have been a draw for pharma companies, offering high prices, swift regulatory reviews, and often extended marketing exclusiv

News

breath diagnostics for the developing world

Owlstone secures $6.5M for breath-based diagnostics for infe...

Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of

Biotts claims a first with insulin delivery across skin

Prime editing comes of age as FDA clears human trials

Ono swoops on Deciphera in $2.4 billion takeover

Ex-Ironwood CEO Mark Mallon pops up at George Medicines

Is pharma’s interest in orphan drugs waning?

Owlstone secures $6.5M for breath-based diagnostics for infe...

UK's Claret Capital raises €575m for European biotechs

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks